X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12) 12
humans (10) 10
middle aged (9) 9
aged (8) 8
female (8) 8
male (7) 7
oxidative stress (7) 7
insulin resistance (5) 5
original (5) 5
article (4) 4
endocrinology & metabolism (4) 4
glycation end products, advanced - blood (4) 4
glycotoxins (4) 4
identification (4) 4
inflammation (4) 4
microbiology (4) 4
abridged index medicus (3) 3
bacteria (3) 3
chickens (3) 3
diabetes (3) 3
diabetes mellitus, type 2 - blood (3) 3
diabetes mellitus, type 2 - drug therapy (3) 3
diet (3) 3
glycation end products, advanced - administration & dosage (3) 3
glycation end products, advanced - adverse effects (3) 3
insulin-resistance (3) 3
metabolic syndrome (3) 3
mice (3) 3
original articles (3) 3
orthopedics (3) 3
oxidant stress (3) 3
oxidative stress - drug effects (3) 3
poultry (3) 3
risk (3) 3
risk factors (3) 3
risk-factor (3) 3
aged, 80 and over (2) 2
analysis (2) 2
antimicrobial resistance (2) 2
biomarkers - blood (2) 2
chelating agents - therapeutic use (2) 2
clinical neurology (2) 2
cooking (2) 2
cross-sectional studies (2) 2
database (2) 2
diabetes mellitus, type 2 - physiopathology (2) 2
diabetes-mellitus (2) 2
diabetic complications (2) 2
diabetic nephropathies - blood (2) 2
diabetic nephropathies - drug therapy (2) 2
dietary glycotoxins (2) 2
dinoprost - analogs & derivatives (2) 2
dinoprost - blood (2) 2
disease (2) 2
drug resistance (2) 2
end-products (2) 2
foods (2) 2
genes (2) 2
genomes (2) 2
glycated hemoglobin a - metabolism (2) 2
glycoxidation products (2) 2
halomonas (2) 2
health aspects (2) 2
hypoglycemic agents - therapeutic use (2) 2
inflammation - blood (2) 2
inflammation - drug therapy (2) 2
inflammation - physiopathology (2) 2
insulin resistance - physiology (2) 2
life sciences (2) 2
lysine - analogs & derivatives (2) 2
lysine - blood (2) 2
metabolic syndrome - blood (2) 2
nephropathy (2) 2
nutrition (2) 2
osteoporosis (2) 2
prevalence (2) 2
receptor for advanced glycation end products (2) 2
receptors, immunologic - physiology (2) 2
renal-failure patients (2) 2
research (2) 2
restriction (2) 2
sirtuin 1 - genetics (2) 2
strains (2) 2
urology & nephrology (2) 2
usage (2) 2
3t3-l1 cells (1) 1
abattoirs (1) 1
absorptiometry, photon - methods (1) 1
acrylic cement (1) 1
adiponectin - blood (1) 1
adipose-tissue (1) 1
adolescent (1) 1
adult (1) 1
adults (1) 1
advanced glycation end product (1) 1
advanced glycation endproducts (1) 1
age (1) 1
age factors (1) 1
age receptor-1 (1) 1
ager1 (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Spine Journal, ISSN 0940-6719, 12/2017, Volume 26, Issue 12, pp. 3199 - 3205
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 06/2012, Volume 7, Issue 6, pp. 934 - 942
Background and objectives Increased inflammation and oxidative stress may be caused by proteins and lipids modified by cytotoxic advanced glycation end... 
METABOLIC SYNDROME | OXIDANT STRESS | NEGATIVE REGULATION | DIETARY GLYCOTOXINS | UROLOGY & NEPHROLOGY | RISK | COLESEVELAM HYDROCHLORIDE | RESTRICTION | TYPE-1 | STAGE RENAL-DISEASE | PROGRESSION | Dinoprost - blood | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Polyamines - therapeutic use | Diabetic Nephropathies - blood | Diabetic Nephropathies - diagnosis | Inflammation - blood | Leukocytes - immunology | New York City | Calcium - blood | Glomerular Filtration Rate - drug effects | Diabetic Nephropathies - physiopathology | Time Factors | Inflammation - drug therapy | Lipids - blood | Female | Dinoprost - analogs & derivatives | Inflammation - diagnosis | Sevelamer | Chelating Agents - therapeutic use | Kidney - physiopathology | Severity of Illness Index | Kidney - drug effects | Inflammation Mediators - blood | Calcium Carbonate - therapeutic use | Treatment Outcome | Biomarkers - blood | Cross-Over Studies | Diabetes Mellitus, Type 2 - diagnosis | Diabetes Mellitus, Type 2 - blood | Diabetes Mellitus, Type 2 - physiopathology | Fibroblast Growth Factors - blood | Phosphorus - blood | Glycation End Products, Advanced - blood | Leukocytes - drug effects | Aged | Oxidative Stress - drug effects | Diabetes Mellitus, Type 2 - drug therapy | Inflammation - physiopathology | Original
Journal Article
Diabetologia, ISSN 0012-186X, 10/2016, Volume 59, Issue 10, pp. 2181 - 2192
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 05/2019, Volume 60
Objectives: The aim of our study was to develop an estimation of mean absorbed-dose to the liver using bremsstrahlung SPECT/CT (bSPECT/CT) in patients... 
Dosimeters | Medical imaging | Bremsstrahlung | Energy spectra | Liver | Radiation | Positron emission | Collimation | Radiation therapy | Single photon emission computed tomography | Image reconstruction | Computer programs | Microspheres | Computed tomography | Mathematical analysis | Tomography | Scaling | Software | Dosimetry | Image enhancement | Quantitative analysis
Journal Article
Circulation, ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A11821 - A11821
IntroductionMany recent studies have shown an association between gout and increased cardiovascular risk, however the mechanism by which this occurs is... 
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 05/2015, Volume 100, Issue 5, pp. 1957 - 1966
Journal Article
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 01/2015, Volume 10, Issue 5, pp. 759 - 766
Background and objectives The primary goals were to re-examine whether sevelamer carbonate (SC) reduces advanced glycation end products (AGEs) (methylglyoxal... 
ALL-CAUSE MORTALITY | GLOMERULAR-FILTRATION-RATE | ALBUMINURIA | INSULIN-RESISTANCE | UROLOGY & NEPHROLOGY | RISK | NEPHROPATHY | TNF RECEPTORS 1 | PARADIGM SHIFT | CYSTATIN C | AGE | Single-Blind Method | Dinoprost - blood | Metformin - therapeutic use | Age Factors | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Diabetic Nephropathies - blood | Sirtuin 1 - genetics | Sevelamer - therapeutic use | Female | NF-E2-Related Factor 2 - genetics | Dinoprost - analogs & derivatives | Receptor for Advanced Glycation End Products - genetics | Chelating Agents - therapeutic use | Diabetes Mellitus, Type 2 - complications | Lysine - blood | NF-E2-Related Factor 2 - blood | Receptor for Advanced Glycation End Products - blood | Hypoglycemic Agents - therapeutic use | Lysine - analogs & derivatives | Receptors, Tumor Necrosis Factor, Type I - blood | European Continental Ancestry Group | Receptors, Tumor Necrosis Factor, Type I - genetics | Sirtuin 1 - blood | Adiponectin - blood | Diabetes Mellitus, Type 2 - blood | RNA, Messenger - blood | Albuminuria - drug therapy | Intention to Treat Analysis | Sex Factors | Estrogen Receptor alpha - blood | Glycation End Products, Advanced - blood | Aged | Diabetes Mellitus, Type 2 - drug therapy | Pyruvaldehyde - blood | advanced glycation end product | albuminuria | ethnicity | Original | diabetic nephropathy | oxidative stress
Journal Article
Journal Article